Breast Cancer 2025 is set to take place on April 07-08, 2025, in Vancouver,Canada. This premier Breast Cancer Conference focuses on the theme 'Global Perspectives on Breast Cancer Research and Care,' offering an unparalleled platform for researchers, cli
Find the latest Breast Cancer news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.
Among the study results, the risk of coronavirus infection among breast cancer patients who received chemotherapy was not greater than the risk for those who received treatments that were not expected to hinder their immune systems. Treatment also did not increase their risk of death ...
Of speaking out about his experience, Roundtree said, “It makes it easier for others who may be going through the same thing. When I tell other men, the reaction is, ’Really?’ They’re shocked. But I’m not embarrassed.” Roundtree passed away in October 2023 of pancreatic cancer. ...
[6] O'Shaughnessy J, Schwartzberg L, Piccart M, et al. A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-,hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane. 2020 SABCS. Abstract GS...
Cancer Survivors Who Experience Functional Limitations Have Doubled in Past 20 Years Erin Hunter, Assistant Editor June 9th 2023 There are 8 million cancer survivors who may have limitations in their daily functional ability. Read More Oncology Pharmacists Connect Meeting Promises Clinical Updates, Oppor...
Women who are concerned about BC recurrence often choose mastectomy [23]. Both procedures are safe and routinely used [24]. Information such as tumor size, lymph node involvement, cancer stage and personal beliefs should be considered when choosing the surgical procedure to be performed. The ...
Pathological complete response (pCR) after neoadjuvant systemic treatment (NST) is an important prognostic factor in HER2-positive breast cancer. The majority of HER2-positive breast cancers are amplified at the HER2 gene locus, several genes are co-amplified with HER2, and a subset of them are ...
The risk of developing high-grade immune-related AEs was heightened among patients with breast cancer who were older and who had chronic kidney disease. Dr Grinshpun on Ultra-Sensitive ctDNA Detection in HR+ Early Breast Cancer By Albert Grinshpun, MD, MSc December 14th 2024 Albert Grinshp...
PO3-08-09 Unique molecular signatures of germline mutations in low expression of human epidermal growth factor receptor 2 (HER2) breast cancer 人表皮生长因子受体2 (HER2)低表达乳腺癌胚系突变的独特分子特征 第一作者:廖宁(广东省人民医院) PO3-08-10 Somatic mutations of a multigene panel in Chinese...